hotspot -WSS

hotspot

author：fashion 2025-09-30 20:19:59 - browse：4732

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： The FDA must approve intranasal treatments for anaphylaxis

WSS

Asahi Kasei to buy Calliditas, picking up kidney disease drug

The FDA must approve intranasal treatments for anaphylaxis

Feng Zhang, Grail founder join forces on new gene editing startup

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Stroke rates rising, especially in working

focus

hotspot

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Clinicians often fail to acknowledge the pain caused by long Covid

Novavax promises a turnaround & Lilly roils the obesity market

Antibiotic resistance and the global rise in human conflict

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Guardant Health colon cancer test endorsed by FDA advisory panel

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A single drug, study failures leave Anavex with nothing but cash

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

knowledge

Stroke rates rising, especially in working

How a scoliosis diagnosis changed the life of one young dancer

Stroke rates rising, especially in working

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

JPM: CVS says Medicare Advantage patients are impacting profits

Burning questions for the 2024 JPM Healthcare Conference

leisure time

Wikipedia

knowledge

explore